Advertisement
Screener

ANAVEX LIFE SCIENCES CORP. (AVXL) Proceeds from Related Party Debt

2.8 / 5 stars · 68/120 Roast Me

ANAVEX LIFE SCIENCES CORP. Proceeds from Related Party Debt

ANAVEX LIFE SCIENCES CORP. (AVXL) reported Proceeds from Related Party Debt of $33.66 thousand for the 122-month period ending 2014-03-31, per its 10-Q/A filed 2014-05-30.

Discontinued › Cash Flow › Financing Activities

us-gaap:ProceedsFromRelatedPartyDebt · last filed 2014-05-30

  • ANAVEX LIFE SCIENCES CORP. proceeds from related party debt for the quarter ending 2014-03-31 was $0.00.
  • ANAVEX LIFE SCIENCES CORP. proceeds from related party debt for the quarter ending 2013-12-31 was $0.00.
  • ANAVEX LIFE SCIENCES CORP. proceeds from related party debt for the quarter ending 2013-09-30 was $0.00.
  • ANAVEX LIFE SCIENCES CORP. proceeds from related party debt for the quarter ending 2013-06-30 was $0.00.
  • ANAVEX LIFE SCIENCES CORP. proceeds from related party debt for fiscal 2013 was $0.00.
  • ANAVEX LIFE SCIENCES CORP. proceeds from related party debt for fiscal 2012 was $0.00.
  • ANAVEX LIFE SCIENCES CORP. proceeds from related party debt for fiscal 2011 was $0.00.
  • ANAVEX LIFE SCIENCES CORP. proceeds from related party debt for fiscal 2010 was $0.00.
Period endProceeds from Related Party Debt 3 monthProceeds from Related Party Debt 6 monthProceeds from Related Party Debt 9 monthProceeds from Related Party Debt 12 monthProceeds from Related Party Debt 89 monthProceeds from Related Party Debt 92 monthProceeds from Related Party Debt 95 monthProceeds from Related Party Debt 98 monthProceeds from Related Party Debt 101 monthProceeds from Related Party Debt 104 monthProceeds from Related Party Debt 107 monthProceeds from Related Party Debt 110 monthProceeds from Related Party Debt 113 monthProceeds from Related Party Debt 116 monthProceeds from Related Party Debt 119 monthProceeds from Related Party Debt 122 month
2014-03-31$0.00
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2014-05-30
$0.00
10-Q/A · filed 2014-05-30
$0.00
derived: sum of 3 quarters · filed 2014-05-30
$0.00
derived: sum of 4 quarters · filed 2014-05-30
$33.66K
10-Q/A · filed 2014-05-30
2013-12-31$0.00
10-Q · filed 2014-02-14
$0.00
derived: sum of 2 quarters · filed 2014-02-14
$0.00
derived: sum of 3 quarters · filed 2014-02-14
$0.00
derived: sum of 4 quarters · filed 2014-05-30
$33.66K
10-Q · filed 2014-02-14
2013-09-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30
$0.00
derived: sum of 2 quarters · filed 2013-12-30
$0.00
derived: sum of 3 quarters · filed 2014-05-30
$0.00
10-K · filed 2013-12-30
$33.66K
10-K · filed 2013-12-30
2013-06-30$0.00
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-08-14
$0.00
derived: sum of 2 quarters · filed 2014-05-30
$0.00
10-Q · filed 2013-08-14
$0.00
derived: sum of 4 quarters · filed 2014-05-30
$33.66K
10-Q · filed 2013-08-14
2013-03-31$0.00
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2014-05-30
$0.00
10-Q/A · filed 2014-05-30
$0.00
derived: sum of 3 quarters · filed 2014-05-30
$0.00
derived: sum of 4 quarters · filed 2014-05-30
$33.66K
10-Q · filed 2013-05-17
2012-12-31$0.00
10-Q · filed 2014-02-14
$0.00
derived: sum of 2 quarters · filed 2014-02-14
$0.00
derived: sum of 3 quarters · filed 2014-02-14
$0.00
derived: sum of 4 quarters · filed 2014-02-14
$33.66K
10-Q · filed 2013-02-14
2012-09-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30
$0.00
derived: sum of 2 quarters · filed 2013-12-30
$0.00
derived: sum of 3 quarters · filed 2013-12-30
$0.00
10-K · filed 2013-12-30
$33.66K
10-K · filed 2012-12-31
2012-06-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-14
$0.00
derived: sum of 2 quarters · filed 2013-08-14
$0.00
10-Q · filed 2013-08-14
$0.00
derived: sum of 4 quarters · filed 2013-08-14
$33.66K
10-Q · filed 2012-08-17
2012-03-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-17
$0.00
10-Q · filed 2013-05-17
$0.00
derived: sum of 3 quarters · filed 2013-05-17
$0.00
derived: sum of 4 quarters · filed 2013-05-17
$33.66K
10-Q · filed 2012-05-15
2011-12-31$0.00
10-Q · filed 2013-02-14
$0.00
derived: sum of 2 quarters · filed 2013-02-14
$0.00
derived: sum of 3 quarters · filed 2013-02-14
$0.00
derived: sum of 4 quarters · filed 2013-02-14
$33.66K
10-Q · filed 2012-02-14
2011-09-30$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31
$0.00
derived: sum of 2 quarters · filed 2012-12-31
$0.00
derived: sum of 3 quarters · filed 2012-12-31
$0.00
10-K · filed 2012-12-31
$33.66K
10-K · filed 2011-12-22
2011-06-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-08-17
$0.00
derived: sum of 2 quarters · filed 2012-08-17
$0.00
10-Q · filed 2012-08-17
$33.66K
10-Q · filed 2011-08-12
2011-03-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-05-15
$0.00
10-Q · filed 2012-05-15
2010-12-31$0.00
10-Q · filed 2012-02-14
2010-09-30$0.00
10-K · filed 2011-12-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
Alector, Inc. (ALEC)United States$0.213B-1.90
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95